PRO-DEX, INC. Form DEFA14A: Additional definitive proxy soliciting materials
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-10-07: Form DEFA14A; Description DEFINITIVE 14A ADDITIONAL MATERIALS; Document pdex_defa14a.htm.
- 2024-10-08: Form DEFA14A; Description DEFINITIVE 14A ADDITIOINAL MATERIALS; Document pdex_defa14a.htm.
- 2023-10-27: Form DEFA14A; Description DEFINITIVE 14A ADDITIONAL MATERIALS; Document pdex_defa14a.htm.
- 2022-10-03: Form DEFA14A; Description DEFINITIVE ADDITIONAL MATERIAL; Document pdex_14a.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-10-07 | DEFA14A | DEFINITIVE 14A ADDITIONAL MATERIALS | pdex_defa14a.htm | |
| 2024-10-08 | DEFA14A | DEFINITIVE 14A ADDITIOINAL MATERIALS | pdex_defa14a.htm | |
| 2023-10-27 | DEFA14A | DEFINITIVE 14A ADDITIONAL MATERIALS | pdex_defa14a.htm | |
| 2022-10-03 | DEFA14A | DEFINITIVE ADDITIONAL MATERIAL | pdex_14a.htm | |
| 2021-10-05 | DEFA14A | DEFINITIVE ADDITIONAL MATERIAL | pdex_14a.htm | |
| 2020-10-06 | DEFA14A | DEFINITIVE ADDITIONAL MATERIAL | pdex_14a.htm | |
| 2019-10-07 | DEFA14A | DEFINITIVE ADDITIONAL MATERIAL | pdex_14a.htm | |
| 2018-10-05 | DEFA14A | DEFINITIVE ADDITIONAL MATERIAL | pdex_14a.htm | |
| 2017-10-19 | DEFA14A | DEFINITIVE ADDITIONAL MATERIAL | pdex_14a.htm | |
| 2013-01-10 | DEFA14A | DEFA14A | d465743ddefa14a.htm | |
| 2013-01-10 | DEFA14A | DEFA14A | d465739ddefa14a.htm | |
| 2013-01-07 | DEFA14A | DEFA14A | d463178ddefa14a.htm | |
| 2013-01-02 | DEFA14A | DEFA14A | d459566ddefa14a.htm | |
| 2012-12-28 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | d461698ddefa14a.htm | |
| 2012-12-07 | DEFA14A | SHAREHOLDER LETTER | d445986ddefa14a.htm | |
| 2011-10-17 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | d244497ddefa14a.htm | |
| 2011-10-12 | DEFA14A | NOTICE OF INTERNET AVAILABILITY | d242526ddefa14a.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |